Trial Profile
Phase II study of dose intensive temozolomide in elderly adults with newly diagnosed glioblastoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2009
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 21 Jan 2009 Planned end date (Jun 2007) added as reported by ClinicalTrials.gov.
- 21 Jan 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 21 Jan 2009 Actual patient number (1) added as reported by ClinicalTrials.gov.